Outcomes of Brentuximab Vedotin Monotherapy in Refractory/Relapsed Classical Hodgkin's Lymphoma: A Multi-Center Retrospective Study on Survival and Safety için istatistikler

Toplam ziyaret

views
Outcomes of Brentuximab Vedotin Monotherapy in Refractory/Relapsed Classical Hodgkin's Lymphoma: A Multi-Center Retrospective Study on Survival and Safety 0

Aylık toplam ziyaret

views
Ekim 2025 0
Kasım 2025 0
Aralık 2025 0
Ocak 2026 0
Şubat 2026 0
Mart 2026 0
Nisan 2026 0